AG
KRRO icon

Algert Global’s Korro Bio KRRO Stock Holding History

Algert Global’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$217K Sell
19,185
-7,880
-29% -$86.8K ﹤0.01% 1066
2025
Q4 		$217K Buy
27,065
+19,957
+281% +$467K ﹤0.01% 1047
2025
Q3 		$340K Buy
+7,108
New +$158K 0.01% 977
2022
Q2 		– Sell
-495
Closed -$52K – 1302
2022
Q1 		$52K Buy
+495
New +$94.6K ﹤0.01% 1141

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Algert Global's KRRO Position: Q1 2026 in Review

Algert Global reduced its Korro Bio (KRRO) stake by 29% in Q1 2026, selling an estimated $86.8K and leaving 19,185 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #1066.

Algert Global first reported a position in KRRO in Q1 2022 and has held it in 4 quarters since. The position peaked at $340K in Q3 2025. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • Algert Global held 19,185 shares of Korro Bio worth $217K as of Q1 2026.
  • Algert Global sold 7,880 Korro Bio shares in Q1 2026, an estimated $86.8K.
  • Korro Bio made up ﹤0.01% of Algert Global's portfolio in Q1 2026, its #1066 holding.
  • Algert Global first reported a position in Korro Bio in Q1 2022 and has held it in 4 quarters since.
  • Algert Global's Korro Bio position peaked at $340K in Q3 2025.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.